Pharmac is removing renewal criteria for three stimulant ADHD medicines

From December, methylphenidate , dexamfetamine and modafinil will need just the one signoff when being prescribed by a specialist, instead of every two years.

Advocacy group Aroreretini Aotearoa, says the changes will improve productivity for the ADHD community, by almost 57-million-dollars.

Chief medical officer David Hughes says it will streamline treatment.

He says regular monitoring will need to continue to ensure patients are benefiting from treatment, and that it stays in line with specialist recommendations.